Menu
Back to Journals » Clinical Pharmacology: Advances and Applications
Clinical Pharmacology: Advances and Applications
- View all (177)
- Volume 11, 2019 (5)
- Volume 10, 2018 (19)
- Volume 9, 2017 (19)
- Volume 8, 2016 (20)
- Volume 7, 2015 (14)
- Volume 6, 2014 (23)
- Volume 5, 2013 (30)
- Volume 4, 2012 (11)
- Volume 3, 2011 (7)
- Volume 2, 2010 (28)
- Volume 1, 2009 (1)
Journal Articles:
- 177 records -
Effects of formulation types on pharmacodynamics of warfarin in patients with cerebral infarction and dysphagia
Kim YJ, Jeong JW, Song Y, Koo TS
Clinical Pharmacology: Advances and Applications 2019, 11:51-56
Published Date: 13 March 2019
Modeling and simulation of the endogenous CYP3A induction marker 4β-hydroxycholesterol during enasidenib treatment
Li Y, Connarn JN, Chen J, Tong Z, Palmisano M, Zhou S
Clinical Pharmacology: Advances and Applications 2019, 11:39-50
Published Date: 15 February 2019
Assessing the effect of omega-3 fatty acid combined with vitamin D3 versus vitamin D3 alone on estradiol levels: a randomized, placebo-controlled trial in females with vitamin D deficiency
Al-Shaer AH, Abu-Samak MS, Hasoun LZ, Mohammad BA, Basheti IA
Clinical Pharmacology: Advances and Applications 2019, 11:25-37
Published Date: 4 February 2019
Small-cell lung cancer growth inhibition: synergism between NMDA receptor blockade and chemotherapy
North WG, Liu F, Dragnev KH, Demidenko E
Clinical Pharmacology: Advances and Applications 2019, 11:15-23
Published Date: 23 January 2019
Method development and validation of ursodiol and its major metabolites in human plasma by HPLC-tandem mass spectrometry
Pinto MC, Chorfi Berton D, Cavenatti de Oliveira A, Lazaro CM, Aparecida Calafatti Carandina S
Clinical Pharmacology: Advances and Applications 2019, 11:1-13
Published Date: 4 January 2019
Correlation between measured and calculated free phenytoin serum concentration in neurointensive care patients with hypoalbuminemia
Javadi SS, Mahjub R, Taher A, Mohammadi Y, Mehrpooya M
Clinical Pharmacology: Advances and Applications 2018, 10:183-190
Published Date: 13 December 2018
Treatment of acne with a combination of propolis, tea tree oil, and Aloe vera compared to erythromycin cream: two double-blind investigations
Mazzarello V, Donadu MG, Ferrari M, Piga G, Usai D, Zanetti S, Sotgiu MA
Clinical Pharmacology: Advances and Applications 2018, 10:175-181
Published Date: 13 December 2018
Species difference in paclitaxel disposition correlated with poor pharmacological efficacy translation from mice to humans
Li YF, Zhang C, Zhou S, He M, Zhang H, Chen N, Li F, Luan X, Pai M, Yuan H, Sun D, Li Y
Clinical Pharmacology: Advances and Applications 2018, 10:165-174
Published Date: 8 November 2018
Evaluation of the single-dose pharmacokinetics and pharmacodynamics of apixaban in healthy Japanese and Caucasian subjects
Frost C, Shenker A, Jhee S, Yu Z, Wang J, Bragat A, Pursley J, LaCreta F
Clinical Pharmacology: Advances and Applications 2018, 10:153-163
Published Date: 24 October 2018
12-month effects of incretins versus SGLT2-Inhibitors on cognitive performance and metabolic profile. A randomized clinical trial in the elderly with Type-2 diabetes mellitus
Perna S, Mainardi M, Astrone P, Gozzer C, Biava A, Bacchio R, Spadaccini D, Solerte SB, Rondanelli M
Clinical Pharmacology: Advances and Applications 2018, 10:141-151
Published Date: 9 October 2018
The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells
Al-Keilani MS, Alzoubi KH, Jaradat SA
Clinical Pharmacology: Advances and Applications 2018, 10:135-140
Published Date: 9 October 2018
Mechanisms and the clinical relevance of complex drug–drug interactions
Roberts AG, Gibbs ME
Clinical Pharmacology: Advances and Applications 2018, 10:123-134
Published Date: 27 September 2018
Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin
Oh F, Todhunter D, Taras E, Vallera DA, Borgatti A
Clinical Pharmacology: Advances and Applications 2018, 10:113-121
Published Date: 26 September 2018
Pharmacokinetics of evocalcet in secondary hyperparathyroidism patients receiving hemodialysis: first-in-patient clinical trial in Japan
Shigematsu T, Shimazaki R, Fukagawa M, Akizawa T
Clinical Pharmacology: Advances and Applications 2018, 10:101-111
Published Date: 11 September 2018
A Phase I, open-label, randomized, crossover study in healthy subjects to evaluate the bioavailability of, and the food effect on, a pomalidomide oral liquid suspension
Li Y, Liu L, Huang L, Wang X, Hoffmann M, Reyes J, Palmisano M, Zhou S
Clinical Pharmacology: Advances and Applications 2018, 10:89-99
Published Date: 19 July 2018
Safety and neutralizing rabies antibody in healthy subjects given a single dose of rabies immune globulin caprylate/chromatography purified
Hanna K, Cruz MC, Mondou E, Corsi E, Vandeberg P
Clinical Pharmacology: Advances and Applications 2018, 10:79-88
Published Date: 26 June 2018
Pharmacokinetic evaluation of D-ribose after oral and intravenous administration to healthy rabbits
Alzoubi KH, Ismail ZB, AL-Essa MK, Alshogran OY, Abutayeh RF, Abu-Baker N
Clinical Pharmacology: Advances and Applications 2018, 10:73-78
Published Date: 12 June 2018
A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum]
Frost C, Song Y, Barrett YC, Wang J, Pursley J, Boyd RA, LaCreta F
Clinical Pharmacology: Advances and Applications 2018, 10:71-72
Published Date: 11 June 2018
Anti-factor Xa levels in obese patients receiving enoxaparin for treatment and prophylaxis indications
Tahaineh L, Edaily SM, Gharaibeh SF
Clinical Pharmacology: Advances and Applications 2018, 10:63-70
Published Date: 18 May 2018
Distribution of pomalidomide into semen of healthy male subjects after multiple doses
Li Y, Wang X, Liu L, Reyes J, Palmisano M, Zhou S
Clinical Pharmacology: Advances and Applications 2018, 10:53-62
Published Date: 7 May 2018
Pharmacokinetic equivalence study of nonsteroidal anti-inflammatory drug etoricoxib
Tjandrawinata RR, Setiawati A, Nofiarny D, Susanto LW, Setiawati E
Clinical Pharmacology: Advances and Applications 2018, 10:43-51
Published Date: 6 April 2018
Safinamide: an add-on treatment for managing Parkinson’s disease
Müller T
Clinical Pharmacology: Advances and Applications 2018, 10:31-41
Published Date: 5 April 2018
Pramlintide, an antidiabetic, is antineoplastic in colorectal cancer and synergizes with conventional chemotherapy
Al-Keilani MS, Alsmadi DH, Darweesh RS, Alzoubi KH
Clinical Pharmacology: Advances and Applications 2018, 10:23-29
Published Date: 5 March 2018
A review of the pharmacology and clinical efficacy of brivaracetam
Klein P, Diaz A, Gasalla T, Whitesides J
Clinical Pharmacology: Advances and Applications 2018, 10:1-22
Published Date: 19 January 2018
CRTH2 antagonists in asthma: current perspectives
Singh D, Ravi A, Southworth T
Clinical Pharmacology: Advances and Applications 2017, 9:165-173
Published Date: 15 December 2017
Olaratumab: a platelet-derived growth factor receptor-α-blocking antibody for the treatment of soft tissue sarcoma
Pender A, Jones RL
Clinical Pharmacology: Advances and Applications 2017, 9:159-164
Published Date: 4 December 2017
Role of afatinib in the treatment of advanced lung squamous cell carcinoma
Vavalà T
Clinical Pharmacology: Advances and Applications 2017, 9:147-157
Published Date: 27 November 2017
Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function
Li Y, Wang X, O’Mara E, Dimopoulos MA, Sonneveld P, Weisel KC, Matous J, Siegel DS, Shah JJ, Kueenburg E, Sternas L, Cavanaugh C, Zaki M, Palmisano M, Zhou S
Clinical Pharmacology: Advances and Applications 2017, 9:133-145
Published Date: 8 November 2017
Assessment of prescribed medications and pattern of distribution for potential drug–drug interactions among chronic kidney disease patients attending the Nephrology Clinic of Lagos University Teaching Hospital in Sub-Saharan West Africa
Fasipe OJ, Akhideno PE, Nwaiwu O, Adelosoye AA
Clinical Pharmacology: Advances and Applications 2017, 9:125-132
Published Date: 26 October 2017
Possible involvement of ROS generation in vorinostat pretreatment induced enhancement of the antibacterial activity of ciprofloxacin
Masadeh MM, Alzoubi KH, Al-azzam SI, Al-buhairan AM
Clinical Pharmacology: Advances and Applications 2017, 9:119-124
Published Date: 17 October 2017
Antipsychotic prescription to identify delirium: results from two cohorts
Zimmerman KM, Paquin AM, Rudolph JL
Clinical Pharmacology: Advances and Applications 2017, 9:113-117
Published Date: 3 October 2017
Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseases
Dreesen E, Bossuyt P, Mulleman D, Gils A, Pascual-Salcedo D
Clinical Pharmacology: Advances and Applications 2017, 9:101-111
Published Date: 3 October 2017
Etanercept (Enbrel®) alternative storage at ambient temperature
Shannon E, Daffy J, Jones H, Paulson A, Vicik SM
Clinical Pharmacology: Advances and Applications 2017, 9:87-99
Published Date: 21 July 2017
NMDA receptors are important regulators of pancreatic cancer and are potential targets for treatment
North WG, Liu F, Lin LZ, Tian R, Akerman B
Clinical Pharmacology: Advances and Applications 2017, 9:79-86
Published Date: 17 July 2017
Adverse reactions in leprosy patients who underwent dapsone multidrug therapy: a retrospective study
Guragain S, Upadhayay N, Bhattarai BM
Clinical Pharmacology: Advances and Applications 2017, 9:73-78
Published Date: 29 June 2017
Prediction of efficacy for conversion from adjunctive therapy to monotherapy with eslicarbazepine acetate 800 mg once daily for partial-onset epilepsy
Sunkaraneni S, Passarell JA, Ludwig EA, Fiedler-Kelly J, Pitner JK, Grinnell TA, Blum D
Clinical Pharmacology: Advances and Applications 2017, 9:65-72
Published Date: 27 June 2017
An integrated epidemiological and neural net model of the warfarin effect in managed care patients
Jacobs DM, Stefanovic F, Wilton G, Gomez-Caminero A, Schentag JJ
Clinical Pharmacology: Advances and Applications 2017, 9:55-64
Published Date: 18 May 2017
Comparative analysis of the safety and tolerability of fixed-dose artesunate/amodiaquine versus artemether/lumefantrine combinations for uncomplicated falciparum malaria in pregnancy: a randomized open label study
Iribhogbe OI, Emmanuel I, Odianosen M
Clinical Pharmacology: Advances and Applications 2017, 9:45-54
Published Date: 9 May 2017
Pharmacokinetics and outcome of tazobactam/piperacillin in Japanese patients undergoing low-flow continuous renal replacement therapy: dosage considerations
Kohama H, Ide T, Ikawa K, Morikawa N, Nishi S
Clinical Pharmacology: Advances and Applications 2017, 9:39-44
Published Date: 24 February 2017
Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery: in vitro pharmaceutics and Caco-2 permeability investigations
Spinks CB, Zidan AS, Khan MA, Habib MJ, Faustino PJ
Clinical Pharmacology: Advances and Applications 2017, 9:29-38
Published Date: 23 February 2017
The effect of apixaban on the pharmacokinetics of digoxin and atenolol in healthy subjects
Frost C, Song Y, Yu Z, Wang J, Lee LS, Schuster A, Pollack A, LaCreta F
Clinical Pharmacology: Advances and Applications 2017, 9:19-28
Published Date: 23 February 2017
Effect of food on the pharmacokinetics of dronabinol oral solution versus dronabinol capsules in healthy volunteers
Oh DA, Parikh N, Khurana V, Cognata Smith C, Vetticaden S
Clinical Pharmacology: Advances and Applications 2017, 9:9-17
Published Date: 11 January 2017
Retrospective analysis of the effects of a highly standardized mixture of Berberis aristata, Silybum marianum, and monacolins K and KA in patients with dyslipidemia
Di Pierro F, Putignano P, Ferrara T, Raiola C, Rapacioli G, Villanova N
Clinical Pharmacology: Advances and Applications 2017, 9:1-7
Published Date: 21 December 2016
A Phase I study evaluating the effect of age and weight on the pharmacokinetics of an injectable formulation of diclofenac solubilized with hydroxypropyl-β-cyclodextrin
Goldwater R, Kramer WG, Hamilton DA, Lang E, Wang J, Madden DE, Lacouture PG, Ramaiya A, Carr DB
Clinical Pharmacology: Advances and Applications 2016, 8:203-212
Published Date: 15 December 2016
A case of probable esomeprazole-induced transient liver injury in a pregnant woman with hyperemesis
Thomas B, Mohamed M, Al Hail M, Awwad FA, Wahba RM, Hassan SB, Omar K, El Kassem W, Abdul Rouf P
Clinical Pharmacology: Advances and Applications 2016, 8:199-202
Published Date: 13 December 2016
A prospective, observational study comparing the PK/PD relationships of generic Meropenem (Mercide®) to the innovator brand in critically ill patients
Mer M, Snyman JR, van Rensburg CEJ, van Tonder JJ, Laurens I
Clinical Pharmacology: Advances and Applications 2016, 8:191-198
Published Date: 17 November 2016
LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectives
Atashrazm F, Dzamko N
Clinical Pharmacology: Advances and Applications 2016, 8:177-189
Published Date: 20 October 2016
Skin models for the testing of transdermal drugs
Abd E, Yousuf SA, Pastore MN, Telaprolu K, Mohammed YH, Namjoshi S, Grice JE, Roberts MS
Clinical Pharmacology: Advances and Applications 2016, 8:163-176
Published Date: 19 October 2016
Bioavailability study of dronabinol oral solution versus dronabinol capsules in healthy volunteers
Parikh N, Kramer WG, Khurana V, Cognata Smith C, Vetticaden S
Clinical Pharmacology: Advances and Applications 2016, 8:155-162
Published Date: 12 October 2016
Glibenclamide population pharmacokinetic/pharmacodynamic modeling in South African type 2 diabetic subjects
Rambiritch V, Naidoo P, Pillai G
Clinical Pharmacology: Advances and Applications 2016, 8:141-153
Published Date: 26 September 2016
Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives
Schmidt BZ, Haaf JB, Leal T, Noel S
Clinical Pharmacology: Advances and Applications 2016, 8:127-140
Published Date: 21 September 2016
Exposure-response analysis to assess concentration–QTc relationship of CC-122
Li Y, Carayannopoulos LN,Thomas M, Palmisano M, Zhou S
Clinical Pharmacology: Advances and Applications 2016, 8:117-125
Published Date: 9 September 2016
The effect of weight, body mass index, age, sex , and race on plasma concentrations of subcutaneous sumatriptan: a pooled analysis
Munjal S, Gautam A, Rapoport AM, Fisher DM
Clinical Pharmacology: Advances and Applications 2016, 8:109-116
Published Date: 1 September 2016
Systematic review and network meta-analysis of stroke prevention treatments in patients with atrial fibrillation
Tawfik A, Bielecki JM, Krahn M, Dorian P, Hoch JS, Boon H, Husereau D, Pechlivanoglou P
Clinical Pharmacology: Advances and Applications 2016, 8:93-107
Published Date: 11 August 2016
Population pharmacokinetic modeling of glibenclamide in poorly controlled South African type 2 diabetic subjects
Rambiritch V, Naidoo P, Maharaj B, Pillai G
Clinical Pharmacology: Advances and Applications 2016, 8:83-92
Published Date: 12 July 2016
The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies
Davies M, Chatterjee S, Khunti K
Clinical Pharmacology: Advances and Applications 2016, 8:61-81
Published Date: 23 June 2016
A randomized, double-blind, placebo-, and positive-controlled clinical pilot study to evaluate the efficacy and tolerability of standardized aqueous extracts of Terminalia chebula and Terminalia bellerica in subjects with hyperuricemia
Usharani P, Nutalapati C, Pokuri VK, Kumar CU, Taduri G
Clinical Pharmacology: Advances and Applications 2016, 8:51-59
Published Date: 22 June 2016
Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention
Kreutz RP, Breall JA, Sinha A, von der Lohe E, Kovacs RJ, Flockhart DA
Clinical Pharmacology: Advances and Applications 2016, 8:45-50
Published Date: 3 June 2016
Clinical use and applications of histone deacetylase inhibitors in multiple myeloma
Tandon N, Ramakrishnan V, Kumar SK
Clinical Pharmacology: Advances and Applications 2016, 8:35-44
Published Date: 6 May 2016
Differential pharmacology and clinical utility of empagliflozin in type 2 diabetes
Munir KM, Davis SN
Clinical Pharmacology: Advances and Applications 2016, 8:19-34
Published Date: 20 April 2016
Pharmacokinetic/pharmacodynamic analysis of teicoplanin in patients with MRSA infections
Matsumoto K, Watanabe E, Kanazawa N, Fukamizu T, Shigemi A, Yokoyama Y, Ikawa K, Morikawa N, Takeda Y
Clinical Pharmacology: Advances and Applications 2016, 8:15-18
Published Date: 30 March 2016
Pharmacokinetics of daclizumab high-yield process with repeated administration of the clinical subcutaneous regimen in patients with relapsing-remitting multiple sclerosis
Tran JQ, Othman AA, Mikulskis A, Wolstencroft P, Elkins J
Clinical Pharmacology: Advances and Applications 2016, 8:9-13
Published Date: 11 February 2016
Pharmacokinetics and safety of posaconazole delayed-release tablets for invasive fungal infections
Wiederhold NP
Clinical Pharmacology: Advances and Applications 2016, 8:1-8
Published Date: 23 December 2015
NMDA receptors are expressed in human ovarian cancer tissues and human ovarian cancer cell lines
North WG, Liu F, Tian R, Abbasi H, Akerman B
Clinical Pharmacology: Advances and Applications 2015, 7:111-117
Published Date: 23 October 2015
A clinical evaluation to determine the safety, pharmacokinetics, and pharmacodynamics of an inositol-stabilized arginine silicate dietary supplement in healthy adult males
Kalman DS, Feldman S, Samson A, Krieger DR
Clinical Pharmacology: Advances and Applications 2015, 7:103-109
Published Date: 7 October 2015
Addition of a renin-angiotensin-aldosterone system inhibitor to a calcium channel blocker ameliorates arterial stiffness
Kiuchi S, Hisatake S, Kawasaki M, Hirashima O, Kabuki T, Yamazaki J, Ikeda T
Clinical Pharmacology: Advances and Applications 2015, 7:97-102
Published Date: 8 October 2015
An exploratory, randomized, parallel-group, open-label, relative bioavailability study with an additional two-period crossover food-effect study exploring the pharmacokinetics of two novel formulations of pexmetinib (ARRY-614)
Wollenberg LA, Corson DT, Nugent CA, Peterson FL, Ptaszynski AM, Arrigo A, Mannila CG, Litwiler KS, Bell SJ
Clinical Pharmacology: Advances and Applications 2015, 7:87-95
Published Date: 30 September 2015
Tizanidine-induced acute severe cystitis in a female taking famotidine
Poudel RR, Kafle NK
Clinical Pharmacology: Advances and Applications 2015, 7:83-85
Published Date: 29 July 2015
Pharmacokinetics and skin-tissue penetration of daptomycin in rats
Matsumoto K, Kitaoka M, Kuroda Y, Ikawa K, Morikawa N, Sasaki J, Iketani O, Iwata S, Horino T, Hori S, Kizu J
Clinical Pharmacology: Advances and Applications 2015, 7:79-82
Published Date: 21 May 2015
Pharmacodynamics and Pharmacokinetics of oral factor Xa inhibitors
Persson PB
Clinical Pharmacology: Advances and Applications 2015, 7:77-78
Published Date: 11 May 2015
Pharmacokinetic equivalence study of two formulations of the anticonvulsant pregabalin
Tjandrawinata RR, Setiawati E, Putri RSI, Gunawan VA, Ong F, Susanto LW, Nofiarny D
Clinical Pharmacology: Advances and Applications 2015, 7:69-75
Published Date: 20 April 2015
Expanding antitumor therapeutic windows by targeting cancer-specific nicotinamide adenine dinucleotide phosphate-biogenesis pathways
Chakrabarti G, Gerber DE, Boothman DA
Clinical Pharmacology: Advances and Applications 2015, 7:57-68
Published Date: 27 March 2015
Carbon monoxide: a critical quantitative analysis and review of the extent and limitations of its second messenger function
Levitt DG, Levitt MD
Clinical Pharmacology: Advances and Applications 2015, 7:37-56
Published Date: 26 February 2015
Severe iatrogenic bradycardia related to the combined use of beta-blocking agents and sodium channel blockers
Kawabata M, Yokoyama Y, Sasaki T, Tao S, Ihara K, Shirai Y, Sasano T, Goya M, Furukawa T, Isobe M, Hirao K
Clinical Pharmacology: Advances and Applications 2015, 7:29-36
Published Date: 16 February 2015
Heparin requirements for full anticoagulation are higher for patients on dabigatran than for those on warfarin – a model-based study
Edrich T, Frendl G, Michaud G, Paschalidis I Ch
Clinical Pharmacology: Advances and Applications 2015, 7:19-27
Published Date: 5 February 2015
Bioavailability of everolimus administered as a single 5 mg tablet versus five 1 mg tablets: a randomized, open-label, two-way crossover study of healthy volunteers
Thudium K, Gallo J, Bouillaud E, Sachs C, Eddy S, Cheung W
Clinical Pharmacology: Advances and Applications 2015, 7:11-17
Published Date: 22 January 2015
Effects of food and alcohol on the pharmacokinetics of an oral, extended-release formulation of hydrocodone in healthy volunteers
Farr SJ, Robinson CY, Rubino CM
Clinical Pharmacology: Advances and Applications 2015, 7:1-9
Published Date: 19 January 2015
Enantiomer-selective pharmacokinetics, oral bioavailability, and sex effects of various alpha-lipoic acid dosage forms
Hermann R, Mungo J, Cnota PJ, Ziegler D
Clinical Pharmacology: Advances and Applications 2014, 6:195-204
Published Date: 28 November 2014
Parkinson's disease: carbidopa, nausea, and dyskinesia
Hinz M, Stein A, Cole T
Clinical Pharmacology: Advances and Applications 2014, 6:189-194
Published Date: 14 November 2014
A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban
Frost C, Song Y, Barrett YC, Wang J, Pursley J, Boyd RA, LaCreta F
Clinical Pharmacology: Advances and Applications 2014, 6:179-187
Published Date: 13 November 2014
Evaluating the effects of dexmedetomidine compared to propofol as adjunctive therapy in patients with alcohol withdrawal
Lizotte RJ, Kappes JA, Bartel BJ, Hayes KM, Lesselyoung VL
Clinical Pharmacology: Advances and Applications 2014, 6:171-177
Published Date: 31 October 2014
The Parkinson's disease death rate: carbidopa and vitamin B6
Hinz M, Stein A, Cole T
Clinical Pharmacology: Advances and Applications 2014, 6:161-169
Published Date: 21 October 2014
Lack of effect of ezogabine/retigabine on the pharmacokinetics of digoxin in healthy individuals: results from a drug–drug interaction study
Tompson DJ, Crean CS, Buraglio M, Arumugham T
Clinical Pharmacology: Advances and Applications 2014, 6:149-159
Published Date: 13 October 2014
Arbekacin: another novel agent for treating infections due to methicillin-resistant Staphylococcus aureus and multidrug-resistant Gram-negative pathogens
Matsumoto T
Clinical Pharmacology: Advances and Applications 2014, 6:139-148
Published Date: 26 September 2014
Melatonergic drugs in development
Carocci A, Catalano A, Sinicropi MS
Clinical Pharmacology: Advances and Applications 2014, 6:127-137
Published Date: 18 September 2014
Reducing medication errors in critical care: a multimodal approach
Kruer RM, Jarrell AS, Latif A
Clinical Pharmacology: Advances and Applications 2014, 6:117-126
Published Date: 1 September 2014
Differential renal adverse effects of ibuprofen and indomethacin in preterm infants: a review
Pacifici GM
Clinical Pharmacology: Advances and Applications 2014, 6:111-116
Published Date: 31 July 2014
Administration of supplemental L-tyrosine with phenelzine: a clinical literature review
Hinz M, Stein A, Cole T, Ryan P
Clinical Pharmacology: Advances and Applications 2014, 6:107-110
Published Date: 22 July 2014
Effect of age and sex on warfarin dosing
Khoury G, Sheikh-Taha M
Clinical Pharmacology: Advances and Applications 2014, 6:103-106
Published Date: 12 July 2014
In vitro microdialysis membrane efficiency of broad-spectrum antibiotics in combination and alone
MacVane SH, Housman ST, Nicolau DP
Clinical Pharmacology: Advances and Applications 2014, 6:97-101
Published Date: 5 June 2014
Incidence and management of adverse events in patients with relapsed and/or refractory multiple myeloma receiving single-agent carfilzomib
Harvey RD
Clinical Pharmacology: Advances and Applications 2014, 6:87-96
Published Date: 8 May 2014
Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetes
Nakamura M, Sasai N, Hisatome I, Ichida K
Clinical Pharmacology: Advances and Applications 2014, 6:79-86
Published Date: 3 May 2014
Analysis of factors affecting rehospitalization of patients with chronic kidney disease after educational hospitalization
Kose E, An T, Kikkawa A, Matsumoto Y, Hayashi H
Clinical Pharmacology: Advances and Applications 2014, 6:71-78
Published Date: 8 April 2014
Glibenclamide in patients with poorly controlled type 2 diabetes: a 12-week, prospective, single-center, open-label, dose-escalation study
Rambiritch V, Maharaj B, Naidoo P
Clinical Pharmacology: Advances and Applications 2014, 6:63-69
Published Date: 4 April 2014
Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects [Corrigendum]
Cui Y, Song Y, Wang J, Yu Z, Schuster A, Barrett YC, Frost C
Clinical Pharmacology: Advances and Applications 2014, 6:61-62
Published Date: 27 March 2014
Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers
Nagelschmitz J, Blunck M, Kraetzschmar J, Ludwig M, Wensing G, Hohlfeld T
Clinical Pharmacology: Advances and Applications 2014, 6:51-59
Published Date: 19 March 2014
Population pharmacokinetics of olprinone in healthy male volunteers
Kunisawa T, Kasai H, Suda M, Yoshimura M, Sugawara A, Izumi Y, Iida T, Kurosawa A, Iwasaki H
Clinical Pharmacology: Advances and Applications 2014, 6:43-50
Published Date: 4 March 2014
Pathophysiological processes in multiple sclerosis: focus on nuclear factor erythroid-2-related factor 2 and emerging pathways
Arnold P, Mojumder D, DeToledo J, Lucius R, Wilms H
Clinical Pharmacology: Advances and Applications 2014, 6:35-42
Published Date: 24 February 2014
The clinical potential of influencing Nrf2 signaling in degenerative and immunological disorders
Gao B, Doan A, Hybertson BM
Clinical Pharmacology: Advances and Applications 2014, 6:19-34
Published Date: 3 February 2014
Chronic hepatitis C: future treatment
Wendt A, Adhoute X, Castellani P, Oules V, Ansaldi C, Benali S, Bourlière M
Clinical Pharmacology: Advances and Applications 2014, 6:1-17
Published Date: 8 January 2014
Hemodialysis does not alter in vitro hepatic CYP3A4 and CYP2D6 metabolic activity in uremic serum
Decker BS, O’Neill KD, Chambers MA, Slaven JE, Yu Z, Jones DR, Moe SM
Clinical Pharmacology: Advances and Applications 2013, 5:193-199
Published Date: 10 December 2013
Cytochrome P450 3A4*22, PPAR-α, and ARNT polymorphisms and clopidogrel response
Kreutz RP, Owens J, Jin Y, Nystrom P, Desta Z, Kreutz Y, Breall JA, Li L, Chiang CW, Kovacs RJ, Flockhart DA
Clinical Pharmacology: Advances and Applications 2013, 5:185-192
Published Date: 9 December 2013
Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects
Cui Y, Song Y, Wang J, Yu Z, Schuster A, Barrett YC, Frost C
Clinical Pharmacology: Advances and Applications 2013, 5:177-184
Published Date: 6 December 2013
Atazanavir–bilirubin interaction: a pharmacokinetic–pharmacodynamic model [Corrigendum]
Lozano R, Domeque N, Apesteguia AF
Clinical Pharmacology: Advances and Applications 2013, 5:175-176
Published Date: 22 November 2013
Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes
Di Pierro F, Putignano P, Villanova N, Montesi L, Moscatiello S, Marchesini G
Clinical Pharmacology: Advances and Applications 2013, 5:167-174
Published Date: 19 November 2013
High-dose, short-interval daptomycin regimen was safe and well tolerated in three patients with chronic renal failure
Yabuno K, Seki M, Miyawaki K, Miwa Y, Tomono K
Clinical Pharmacology: Advances and Applications 2013, 5:161-166
Published Date: 5 November 2013
Atazanavir–bilirubin interaction: a pharmacokinetic–pharmacodynamic model
Lozano R, Domeque N, Apesteguia AF
Clinical Pharmacology: Advances and Applications 2013, 5:153-159
Published Date: 27 September 2013
Reviews of botulinum toxin products in aesthetic use must be accurate, clear and avoid speculation
Pickett A
Clinical Pharmacology: Advances and Applications 2013, 5:149-152
Published Date: 5 September 2013
Comparative safety and efficacy of antithrombotics in the management of venous thromboembolism after knee or hip replacement surgery: focus on rivaroxaban
Kwong LM
Clinical Pharmacology: Advances and Applications 2013, 5:143-148
Published Date: 2 August 2013
Single-dose fentanyl sublingual spray for breakthrough cancer pain
Taylor DR
Clinical Pharmacology: Advances and Applications 2013, 5:131-141
Published Date: 24 July 2013
Impact of denosumab on bone mass in cancer patients
Brown-Glaberman U, Stopeck AT
Clinical Pharmacology: Advances and Applications 2013, 5:117-129
Published Date: 4 July 2013
Synthetic cathinone abuse
Capriola M
Clinical Pharmacology: Advances and Applications 2013, 5:109-115
Published Date: 2 July 2013
Clinical effectiveness of baclofen for the treatment of alcohol dependence: a review
Brennan JL, Leung JG, Gagliardi JP, Rivelli SK, Muzyk AJ
Clinical Pharmacology: Advances and Applications 2013, 5:99-107
Published Date: 3 July 2013
Differential effects of dosing regimen on the safety and efficacy of dasatinib: retrospective exposure–response analysis of a Phase III study
Wang X, Roy A, Hochhaus A, Kantarjian HM, Chen TT, Shah NP
Clinical Pharmacology: Advances and Applications 2013, 5:85-97
Published Date: 10 June 2013
Advances in antiplatelet technologies to improve cardiovascular disease morbidity and mortality: a review of ticagrelor
Davis EM, Knezevich JT, Teply RM
Clinical Pharmacology: Advances and Applications 2013, 5:67-83
Published Date: 19 April 2013
Effect of famotidine on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor
Upreti VV, Song Y, Wang J, Byon W, Boyd RA, Pursley JM, LaCreta F, Frost CE
Clinical Pharmacology: Advances and Applications 2013, 5:59-66
Published Date: 16 April 2013
Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven®)
Bartosh NS, Tomlin T, Cable C, Halka K
Clinical Pharmacology: Advances and Applications 2013, 5:53-58
Published Date: 15 March 2013
Differential characteristics of incobotulinumtoxinA and its use in the management of glabellar frown lines
Prager W
Clinical Pharmacology: Advances and Applications 2013, 5:39-52
Published Date: 12 March 2013
Effect of statin therapy on vaspin levels in type 2 diabetic patients
Al-Azzam SI, Alzoubi KH, Abu Abeeleh J, Mhaidat NM, Abu-Abeeleh M
Clinical Pharmacology: Advances and Applications 2013, 5:33-38
Published Date: 20 February 2013
A Phase 1, randomized, open-label crossover study to evaluate the safety and pharmacokinetics of 400 mg albaconazole administered to healthy participants as a tablet formulation versus a capsule formulation
van Rossem K, Lowe JA
Clinical Pharmacology: Advances and Applications 2013, 5:23-31
Published Date: 30 January 2013
Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX® mesalamine. [Corrigendum]
Nanda K, Moss AC
Clinical Pharmacology: Advances and Applications 2013, 5:21-22
Published Date: 22 January 2013
Arginine deprivation therapy for malignant melanoma
Yoon JK, Frankel AE, Feun LG, Ekmekcioglu S, Kim KB
Clinical Pharmacology: Advances and Applications 2013, 5:11-19
Published Date: 27 December 2012
Advances in the management of glioblastoma: the role of temozolomide and MGMT testing
Thomas RP, Recht L, Nagpal S
Clinical Pharmacology: Advances and Applications 2013, 5:1-9
Published Date: 27 December 2012
Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer
Eskander RN, Tewari KS
Clinical Pharmacology: Advances and Applications 2013, 5:55-61
Published Date: 3 October 2013
Immunotherapy of melanoma with the immune costimulatory monoclonal antibodies targeting CD137
Li SY, Liu Y
Clinical Pharmacology: Advances and Applications 2013, 5:47-53
Published Date: 2 September 2013
Immunocytokines: a review of molecules in clinical development for cancer therapy
List T, Neri D
Clinical Pharmacology: Advances and Applications 2013, 5:29-45
Published Date: 20 August 2013
Use of ipilimumab in the treatment of melanoma
Acharya UH, Jeter JM
Clinical Pharmacology: Advances and Applications 2013, 5:21-27
Published Date: 9 August 2013
Toll-like receptor 8: augmentation of innate immunity in platinum resistant ovarian carcinoma
Brueseke TJ, Tewari KS
Clinical Pharmacology: Advances and Applications 2013, 5:13-19
Published Date: 23 May 2013
Clinical and pharmacologic aspects of blinatumomab in the treatment of B-cell acute lymphoblastic leukemia
Portell CA, Wenzell CM, Advani AS
Clinical Pharmacology: Advances and Applications 2013, 5:5-11
Published Date: 12 April 2013
Special issue of clinical pharmacology: advances and applications in new protein therapeutics modulating tumor immunity
Frankel AE
Clinical Pharmacology: Advances and Applications 2013, 5:1-3
Published Date: 26 November 2013
Loading regimen required to rapidly achieve therapeutic trough plasma concentration of teicoplanin and evaluation of clinical features
Seki M, Yabuno K, Miyawaki K, Miwa Y, Tomono K
Clinical Pharmacology: Advances and Applications 2012, 4:71-75
Published Date: 27 November 2012
Pazopanib for the treatment of soft-tissue sarcoma
Heudel P, Cassier P, Derbel O, Dufresne A, Meeus P, Thiesse P, Ranchère-Vince D, Blay JY, Ray-Coquard I
Clinical Pharmacology: Advances and Applications 2012, 4:65-70
Published Date: 26 October 2012
Sedation in the intensive care setting
Hughes CG, McGrane S, Pandharipande PP
Clinical Pharmacology: Advances and Applications 2012, 4:53-63
Published Date: 25 October 2012
Erratum
Samtani MN, Sheehan JJ, Fu D-J, Remmerie B, Sliwa JK, Alphs L
Clinical Pharmacology: Advances and Applications 2012, 4:51-52
Published Date: 13 September 2012
Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX® mesalamine
Nanda K, Moss AC
Clinical Pharmacology: Advances and Applications 2012, 4:41-50
Published Date: 25 July 2012
Management of antipsychotic treatment discontinuation and interruptions using model-based simulations
Samtani MN, Sheehan JJ, Fu D-J, Remmerie B, Sliwa JK, Alphs L
Clinical Pharmacology: Advances and Applications 2012, 4:25-40
Published Date: 16 July 2012
Erratum
Barrese V, Miceli F, Soldovieri MV, Ambrosino P, Iannotti FA, Cilio MR, Taglialatela M
Clinical Pharmacology: Advances and Applications 2012, 4:23-24
Published Date: 26 March 2012
Smoking cessation
Kaur K, Juneja S, Kaushal S
Clinical Pharmacology: Advances and Applications 2012, 4:21-22
Published Date: 15 March 2012
Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel response
Kreutz RP, Nystrom P, Kreutz Y, Miao J, Desta Z, Breall JA, Li L, Chiang C, Kovacs R, Flockhart DA, Jin Y
Clinical Pharmacology: Advances and Applications 2012, 4:13-20
Published Date: 20 February 2012
Phase 1 clinical study of the acute and subacute safety and proof-of-concept efficacy of carbohydrate-derived fulvic acid
Gandy JJ, Meeding JP, Snyman JR, Janse van Rensburg CE
Clinical Pharmacology: Advances and Applications 2012, 4:7-11
Published Date: 17 February 2012
Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial
Hashemi SN, Ghafarian Shirazi HR, Mohammadi A, Zadeh-Bagheri GH, Noorian KH, Malekzadeh M
Clinical Pharmacology: Advances and Applications 2012, 4:1-6
Published Date: 27 January 2012
Drug-resistant tuberculosis: emerging treatment options
Adhvaryu MR, Vakharia BC
Clinical Pharmacology: Advances and Applications 2011, 3:51-67
Published Date: 14 December 2011
Reduced dose maintenance eculizumab in atypical hemolytic uremic syndrome (aHUS): an update on a previous case report
Ohanian M, Cable C, Halka K
Clinical Pharmacology: Advances and Applications 2011, 3:45-50
Published Date: 1 November 2011
Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions
Mahamid M, Mader R, Safadi R
Clinical Pharmacology: Advances and Applications 2011, 3:39-43
Published Date: 4 October 2011
Detemir as a once-daily basal insulin in type 2 diabetes
Nelson SE
Clinical Pharmacology: Advances and Applications 2011, 3:27-37
Published Date: 18 August 2011
Two-way pharmacokinetic interaction studies between saxagliptin and cytochrome P450 substrates or inhibitors: simvastatin, diltiazem extended-release, and ketoconazole
Patel C, Li L, Girgis S, Kornhauser D, Frevert E, Boulton D
Clinical Pharmacology: Advances and Applications 2011, 3:13-25
Published Date: 22 June 2011
Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome
Ohanian M, Cable CC, Halka KK
Clinical Pharmacology: Advances and Applications 2011, 3:5-12
Published Date: 24 May 2011
A case of cephalothin-associated urolithiasis
Ivan WM Lim, Peter JO Stride, Robert L Horvath
Clinical Pharmacology: Advances and Applications 2011, 3:1-3
Published Date: 28 February 2011
Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine
Vincenzo Barrese, Francesco Miceli, Maria Virginia Soldovieri, et al
Clinical Pharmacology: Advances and Applications 2010, 2:225-236
Published Date: 7 December 2010
Editorial Foreword
Arthur E Frankel
Clinical Pharmacology: Advances and Applications 2010, 2:223-224
Published Date: 25 November 2010
Intrapleural therapy in management of complicated parapneumonic effusions and empyema
AlaEldin H Ahmed, Tariq E Yacoub
Clinical Pharmacology: Advances and Applications 2010, 2:213-221
Published Date: 22 November 2010
Analgesic efficacy of oral gabapentin added to standard epidural corticosteroids in patients with failed back surgery
Beyazit Zencirci
Clinical Pharmacology: Advances and Applications 2010, 2:207-211
Published Date: 30 September 2010
A comparative study of DNA damage in patients suffering from diabetes and thyroid dysfunction and complications
Nima V Thakkar, Sunita M Jain
Clinical Pharmacology: Advances and Applications 2010, 2:199-205
Published Date: 22 September 2010
Mitochondrial therapy for Parkinson’s disease: Neuroprotective pharmaconutrition may be disease-modifying
Richard Kones
Clinical Pharmacology: Advances and Applications 2010, 2:185-198
Published Date: 17 September 2010
In vitro cytotoxicity of combinations of dichloroacetate with anticancer platinum compounds
Ulrike Olszewski, Thomas Tuxen Poulsen, Ernst Ulsperger, et al
Clinical Pharmacology: Advances and Applications 2010, 2:177-183
Published Date: 14 September 2010
Reporting of results of interventional studies by the information service of the National Institutes of Health
Tatyana Shamliyan
Clinical Pharmacology: Advances and Applications 2010, 2:169-176
Published Date: 10 September 2010
Clinical efficacy of beta1 selective adrenergic blockers in the treatment of neurocardiogenic syncope – a meta-analysis
Srikanth Vallurupalli, Smita Das
Clinical Pharmacology: Advances and Applications 2010, 2:163-167
Published Date: 15 September 2010
The interaction between clopidogrel and proton pump inhibitors (PPI): is there any clinical relevance?
Rakesh K Sharma, Hanumanth K Reddy, Rohit K Sharma, et al
Clinical Pharmacology: Advances and Applications 2010, 2:155-162
Published Date: 6 September 2010
Testosterone replacement in male hypogonadism
Sanjay Kalra, Navneet Agrawal, Satish Kumar, et al
Clinical Pharmacology: Advances and Applications 2010, 2:149-153
Published Date: 10 September 2010
Differences in hospital glycemic control and insulin requirements in patients recovering from critical illness and those without prior critical illness
April D Miller, Leslie M Phillips, Richard M Schulz, et al
Clinical Pharmacology: Advances and Applications 2010, 2:143-148
Published Date: 24 August 2010
Rituximab in severe skin diseases: target, disease, and dose
Daniel D Bennett, Maro Ohanian, Christian T Cable
Clinical Pharmacology: Advances and Applications 2010, 2:135-141
Published Date: 7 July 2010
Managing insulin resistance: role of liraglutide
Sanjay Kalra, Bharti Kalra, Satish Kumar, et al
Clinical Pharmacology: Advances and Applications 2010, 2:131-134
Published Date: 24 June 2010
Clinical outcomes of antimicrobial lock solutions used in a treatment modality: a retrospective case series analysis
P Brandon Bookstaver, Katherine R Gerrald, Robert R Moran
Clinical Pharmacology: Advances and Applications 2010, 2:123-130
Published Date: 17 June 2010
Somatotropin in the treatment of growth hormone deficiency and Turner syndrome in pediatric patients: a review
Christina Southern Reh, Mitchell E Geffner
Clinical Pharmacology: Advances and Applications 2010, 2:111-122
Published Date: 1 June 2010
A common variant in the adiponectin gene on weight loss and body composition under sibutramine therapy in obesity
Tun-Jen Hsiao, Lawrence Shih-Hsin Wu, Shih-Yi Huang, et al
Clinical Pharmacology: Advances and Applications 2010, 2:105-110
Published Date: 22 June 2010
A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapy
Joe D Strain, Debra K Farver, James R Clem
Clinical Pharmacology: Advances and Applications 2010, 2:95-104
Published Date: 24 May 2010
Lanthanum carbonate is not associated with QT interval modification in hemodialysis patients
Biagio Di Iorio, Emanuele Cucciniello
Clinical Pharmacology: Advances and Applications 2010, 2:89-93
Published Date: 1 June 2010
Effect of rosiglitazone and ramipril on macrovasculopathy in patients with type 2 diabetes: needs longer treatment and/or higher doses?
Sayeeda Rahman, Aziz Al-Shafi Ismail, Shaiful Bhari Ismail, et al
Clinical Pharmacology: Advances and Applications 2010, 2:83-87
Published Date: 20 April 2010
Cosyntropin as a diagnostic agent in the screening of patients for adrenocortical insufficiency
David D Hamilton, Bryan A Cotton
Clinical Pharmacology: Advances and Applications 2010, 2:77-82
Published Date: 27 April 2010
Induction chemotherapy before autologous stem cell transplantation for symptomatic plasma cell myeloma – does it matter?
Henry C Fung, Sunita Nathan, John J Maciejewski
Clinical Pharmacology: Advances and Applications 2010, 2:71-75
Published Date: 14 April 2010
Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician
Guy Hans, Dominique Robert, Johanna Verhulst, et al
Clinical Pharmacology: Advances and Applications 2010, 2:65-70
Published Date: 30 March 2010
Adverse drug effects in hospitalized elderly: Data from the Healthcare Cost and Utilization Project
Tatyana Shamliyan
Clinical Pharmacology: Advances and Applications 2010, 2:41-63
Published Date: 10 May 2010
NMDA receptors are expressed by small-cell lung cancer and are potential targets for effective treatment
William G North, Guohong Gao, Amy Jensen, et al
Clinical Pharmacology: Advances and Applications 2010, 2:31-40
Published Date: 1 April 2010
Pharmacologic agents for smoking cessation: A clinical review
Dilip R Patel, Cynthia Feucht, Lesley Reid, et al
Clinical Pharmacology: Advances and Applications 2010, 2:17-29
Published Date: 7 April 2010
Nanoparticle-labeled stem cells: a novel therapeutic vehicle
Abir O El-Sadik, Afaf El-Ansary, Sherif M Sabry
Clinical Pharmacology: Advances and Applications 2010, 2:9-16
Published Date: 16 March 2010
The pharmacokinetics of valganciclovir prophylaxis in pediatric solid organ transplant patients at risk for Epstein–Barr virus disease
Heather E Vezina, Richard C Brundage, Thomas E Nevins, et al
Clinical Pharmacology: Advances and Applications 2010, 2:1-7
Published Date: 22 December 2009
Chronic fluoxetine treatment increases daytime melatonin synthesis in the rodent
Gillian W Reierson, Claudio A Mastronardi, Julio Licinio, et al
Clinical Pharmacology: Advances and Applications 2009, 1:1-6
Published Date: 7 September 2009